An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Treatment Acquiring Traction Online
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Followers are urged to message these accounts directly for source information, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users injecting substances of uncertain source.
Several experts said the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or prison.
Service Response and Content Removal
According to the social media company, the platform has removed problematic content and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.
Online Trading Operations
Research also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of users, populated with photos of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.
Within moments of entering one group, a seller shared contact information, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Inside these groups, messages display black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.
Her team has already encountered individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject users to potentially serious health risks”.
